Pilar Acedo

6PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 13, 2026
Associations Between Routinely Measured Biomarkers and Pancreatic Cancer Risk in Individuals with Type 2 Diabetes Pre- and Post-Diagnosis.

|Jul 12, 2024
A highly fluorescent and readily accessible all-organic photosensitizer model for advancing image-guided cancer PDT.

Andres Garcia-Sampedro, Alejandro Prieto-Castañeda, Antonia R Agarrabeitia

|Nov 26, 2022
Tissue-Specific Human Extracellular Matrix Scaffolds Promote Pancreatic Tumour Progression and Chemotherapy Resistance.

Walid Al-Akkad, Pilar Acedo, Maria-Giovanna Vilia

|Nov 17, 2021
Smart Nanoparticles as Advanced Anti-Akt Kinase Delivery Systems for Pancreatic Cancer Therapy.

Juan Gonzalez-Valdivieso, Andres Garcia-Sampedro, Andrew R Hall

|Feb 06, 2021
The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies.

Andres Garcia-Sampedro, Gabriella Gaggia, Alexander Ney

|Mar 20, 2019
Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells.

Liren Jiang, Natasha Malik, Pilar Acedo

Pageof 1

Frequent Collaborators

3 joint publications

Andres Garcia-Sampedro

2 joint publications

Alexander Ney

1 joint publications

Liren Jiang

1 joint publications

Natasha Malik